GNAI2 Is a Risk Factor for Gastric Cancer: Study of Tumor Microenvironment (TME) and Establishment of Immune Risk Score (IRS).
Han YuSha LiuZuGuang WuFenfei GaoPublished in: Oxidative medicine and cellular longevity (2022)
The IRS model can be used for survival prediction and GNAI2 serves as a candidate therapeutic target for GC patients.